Moderna, Inc. (NASDAQ:MRNA) is set to release its fourth-quarter earnings on Friday before the opening bell. Here's a look at ...
A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...
Last year, Moderna completed a Phase I/II clinical trial of an investigational influenza vaccine called mRNA-1018, which was tested against H5 and H7 bird flu subtypes. The company said in a ...
A Nevada dairy worker who initially tested positive for bird flu is currently experiencing mild symptoms, including "pink eye ...
While the virus hasn’t made a sustained leap into humans, vaccines and treatments are being developed ahead of an outbreak.
Q&A: From people avoiding wild birds to farmers protecting their animals, Kent State epidemiologist Dr. Tara Smith shares ...
The U.S. government will pay the vaccine maker Moderna $176 million to accelerate development of a pandemic influenza vaccine that could be used to treat bird flu in people, as concern grows about ...
Dr. Paulo H. Verardi, a virologist and head of the Department of Pathobiology and Veterinary Science at the University of ...
In the U.S., bird flu is spreading rapidly on poultry and dairy farms—and data censorship could pose risks to combating it, ...
NanoViricides, Inc. (NYSE American:NNVC) (the 'Company') declared today that it is ready to fight the bird flu with its revolutionary ...
Poultry flocks infected with bird flu are culled to prevent the spread of the virus whereas culling wild birds is generally ...